Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis-Reference-Cited by-同舟云学术

Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis

Published:2022-08 Issue:7 Volume:46 Page:101980
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Nayagam Jeremy S^ORCID,Mandour Mandour O,Taylor Alison,Heneghan Michael A,Dubois Patrick CA,Hayee Bu,Lee Huey Miin,Vadamalayan Babu,Samyn Marianne,Joshi Deepak,Kent Alexandra J

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. AIH and overlap syndrome in inflammatory bowel disease;Trivedi;Clin Res Hepatol Gastroenterol,2012

2. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study;Gregorio;Hepatology,2001

3. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history;Deneau;Hepatology,2013

4. The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration;Deneau;Hepatology,2017

5. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis;Loftus;Gut,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood;JHEP Reports;2024-02

2. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN;Inflammatory Bowel Diseases;2023-09-28